Exelixis
EXEL
#1759
Rank
HK$92.37 B
Marketcap
HK$343.16
Share price
-0.25%
Change (1 day)
22.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company